1[1]Murray CAL.Lopez AD.The Global Burden of Disease:A comprehensive assessment of Cambridge(USA)[M].Harvarvard University Press,1996:412-417,445-448,553-556,808-811
2[2]Woelk:Comparison of St John's wort and impramine for treating depression:randomized trial[J].Br Med J,2000,321(7260):536
3[3]Guoqiang X,Chavko M,Zhang LX,et al.Decreased calcium-dependent constitutive nitric oxide synthase activity in prefrontal cortex in Schizophrenia and depression[J].Schizophrenia Research,2000,58:21-30
4[4]Berstein HG,Stanarius A,Baumann B,et al.Nitric Oxide synthase-containing neurons in the human hypothalamus:Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics[J].Neuroscience,1998,83(3):867-875
5[5]Jan GC,Van Amsterdam,Opperhuizen A.Nitric oxide and bioperterin in depression and stress[J].Psychiatry Research,1999,85:33-38
7[7]Andrew J H,Karen HB,Brandy C,et al.Nitric oxide synthase inhibitors have antidepressant-likeproperties in mice 1.Acute treatments are active in the forced swim test[J].European J Pharmacology,1999,372:207-213
8[8]Beata K,Karen HB,Buyean L,et al.Nitric oxide synthase inhibitors have antidepressant-likeproperties in mice 2.Chronic treatment results in downregulation of cortical renoceptors[J].European J Pharmacology,1999,32:215-220
10[10]Nemeroff CB.Evans DL,Gyillai L,at a1.Double-blind,placebo-controlled comparison of imipramine and parexetine in the treatment of bipolar depression[J].Am J Psychiatry,2001,158:906-912
